These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9321936)

  • 1. Disruption of the mouse cyclooxygenase 1 gene. Characteristics of the mutant and areas of future study.
    Langenbach R; Morham SG; Tiano HF; Loftin CD; Ghanayem BI; Chulada PC; Mahler JF; Davis BJ; Lee CA
    Adv Exp Med Biol; 1997; 407():87-92. PubMed ID: 9321936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of prostaglandin H synthase 2 deficient mice and implications for mechanisms of NSAID action.
    Morham SG; Langenbach R; Mahler J; Smithies O
    Adv Exp Med Biol; 1997; 407():131-8. PubMed ID: 9321943
    [No Abstract]   [Full Text] [Related]  

  • 3. Selective cyclooxygenase-2 inhibitors as potential therapeutic agents for inflammatory diseases.
    Chan CC; Rodger IW
    Adv Exp Med Biol; 1997; 407():157-61. PubMed ID: 9321947
    [No Abstract]   [Full Text] [Related]  

  • 4. The COX-2 inhibitor NS-398 causes T-cell developmental disruptions independent of COX-2 enzyme inhibition.
    Xu H; Izon DJ; Loftin C; Spain LM
    Cell Immunol; 2001 Dec; 214(2):184-93. PubMed ID: 12088417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cyclooxygenases in the spinal cord and the relationship with pain].
    Li SQ; Li WB
    Sheng Li Ke Xue Jin Zhan; 2003 Oct; 34(4):359-60. PubMed ID: 14992024
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclooxygenase-2: its rich diversity of roles and possible application of its selective inhibitors.
    Katori M; Majima M
    Inflamm Res; 2000 Aug; 49(8):367-92. PubMed ID: 11028754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of pharmacologic and/or genetic disruption of cyclooxygenase-1 and cyclooxygenase-2 function in female reproduction in mice.
    Reese J; Zhao X; Ma WG; Brown N; Maziasz TJ; Dey SK
    Endocrinology; 2001 Jul; 142(7):3198-206. PubMed ID: 11416042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant transformation and antineoplastic actions of nonsteroidal antiinflammatory drugs (NSAIDs) on cyclooxygenase-null embryo fibroblasts.
    Zhang X; Morham SG; Langenbach R; Young DA
    J Exp Med; 1999 Aug; 190(4):451-59. PubMed ID: 10449516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective COX-2 inhibitors: are they safe for the stomach?
    Yeomans ND; Cook GA; Giraud AS
    Gastroenterology; 1998 Jul; 115(1):227-9. PubMed ID: 9649482
    [No Abstract]   [Full Text] [Related]  

  • 10. A knock-out for NSAIDs.
    Environ Health Perspect; 1996 Jun; 104(6):598-600. PubMed ID: 8793343
    [No Abstract]   [Full Text] [Related]  

  • 11. [Biological functions of cyclooxygenase 2: control of its expression and activity].
    Jacquemin C
    J Soc Biol; 2000; 194(3-4):189-93. PubMed ID: 11324321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase knockout mice: models for elucidating isoform-specific functions.
    Langenbach R; Loftin C; Lee C; Tiano H
    Biochem Pharmacol; 1999 Oct; 58(8):1237-46. PubMed ID: 10487525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COX-2 inhibitors: better than traditional NSAIDs? Vioxx and Celebrex may be no less risky than NSAIDs.
    Atkinson HG
    Health News; 2002 Aug; 8(8):5. PubMed ID: 12206146
    [No Abstract]   [Full Text] [Related]  

  • 14. The "aspirin" of the new millennium: cyclooxygenase-2 inhibitors.
    Buttar NS; Wang KK
    Mayo Clin Proc; 2000 Oct; 75(10):1027-38. PubMed ID: 11040851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandins: critical roles in pregnancy and colon cancer.
    Majerus PW
    Curr Biol; 1998 Jan; 8(3):R87-9. PubMed ID: 9443907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COX-1 and COX-2 inhibition: current status and future perspective.
    Greyn J; Lauwers MH; Vanlersberghe C; Camu F
    Acta Anaesthesiol Belg; 1998; 49(3):175-83. PubMed ID: 9844704
    [No Abstract]   [Full Text] [Related]  

  • 17. [Current topics in the regulation of prostanoids-1. Inducible cyclooxygenase COX-2 and selective blockers].
    Ohara M; Sawa T
    Masui; 1998 Nov; 47(11):1325-32. PubMed ID: 9852696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II.
    Qi Z; Hao CM; Langenbach RI; Breyer RM; Redha R; Morrow JD; Breyer MD
    J Clin Invest; 2002 Jul; 110(1):61-9. PubMed ID: 12093889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COX-2: a target for prevention and treatment of esophageal cancer.
    Altorki N
    J Surg Res; 2004 Mar; 117(1):114-20. PubMed ID: 15013721
    [No Abstract]   [Full Text] [Related]  

  • 20. The future of NSAID therapy: selective COX-2 inhibitors.
    Vane JR; Botting RM
    Int J Clin Pract; 2000; 54(1):7-9. PubMed ID: 10750251
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.